BridgeMD
Compares treatment options for Rehabilitation
Official title Isolated Versus Combined Cognitive and Motor High-tech Rehabilitation
ClinicalTrials.gov ID: NCT06820125
What this study is testing
- What it's testing
- The first aim of this project is to investigate the effects of different high-tech neurorehabilitation interventions (cognitive, motor, and combined cognitive-motor) on both cognitive and motor disability outcomes in people with multiple sclerosis (MS). The second aim is to identify the cognitive and motor profiles of MS patients who benefit the most from either the combined cognitive-motor rehabilitation intervention or the isolated cognitive or motor treatments.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- presence of mild (one or two neuropsychological tests below the cut-off score, 5th percentile) or severe (more than two neuropsychological tests...
- mild to moderate walking disability with Expanded Disability Status Scale (EDSS) between 3 and 6,
- no relapse or associated steroid use in the past three months,
- adequate visual and auditory capacity to operate computer software.
You likely can't join if
- presence of other neurological disorders than MS,
- major psychiatric disorders,
- high levels of anxiety and/or depression (score\>20 for Depression scale and up to 14 for Anxiety scale on Italian adaptation of the Depression...
- substance abuse,
- any type of rehabilitation intervention in the month prior to recruitment
- pharmacological therapy not well defined and/or changed during the study
See the full eligibility criteria
- presence of mild (one or two neuropsychological tests below the cut-off score, 5th percentile) or severe (more than two neuropsychological tests below the cut-off score, 5th percentile) cognitive impairment,
- mild to moderate walking disability with Expanded Disability Status Scale (EDSS) between 3 and 6,
- no relapse or associated steroid use in the past three months,
- adequate visual and auditory capacity to operate computer software.
- presence of other neurological disorders than MS,
- major psychiatric disorders,
- high levels of anxiety and/or depression (score\>20 for Depression scale and up to 14 for Anxiety scale on Italian adaptation of the Depression, Anxiety and Stress Scale (DASS-21),
- substance abuse,
- any type of rehabilitation intervention in the month prior to recruitment
- pharmacological therapy not well defined and/or changed during the study
- presence of paroxysmal vertigo
- lower limb botulinum toxin injections within the previous 12 weeks
The study team makes the final eligibility decision.
Where it's taking place
- Verona, verona, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Verona, verona, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.